Hormone Replacement Therapy in Chattanooga: A Physician’s Guide












Paul Miranda, MD
Board-Certified in Family Medicine · Emergency Physician · Obesity Medicine Association member

I’m an emergency and Family Medicine physician in Chattanooga, Tennessee, and founder of Summit Metabolic Health. I read every patient chart personally. This article reports on a topic patients keep asking about — it is education, not an endorsement.

Medically reviewed by Paul Miranda, MD

Chattanooga has no shortage of places to get a testosterone prescription. Low-T Center has a location off Gunbarrel Road. Fast Pace Health will see you same-day. A handful of national telehealth brands will ship a vial to your door after a symptom quiz. What almost none of them will do is pull your labs before deciding your dose — and fewer still will have the same physician looking at your chart in month six that looked at it in month one.

I run Summit Metabolic Health the same way whether a patient is on semaglutide or testosterone: confirm the deficiency with labs, screen for what could make treatment risky, then dose to the person in front of me — not to a subscription tier. Here’s what that actually looks like for hormone replacement therapy.

HRT replaces a hormone your body has stopped making at a level that supports normal function — testosterone in men, estrogen and progesterone in women. It is not an energy supplement, and it is not a weight-loss drug on its own, though correcting a genuine deficiency often improves both.

The Endocrine Society’s clinical practice guidelines are specific: testosterone therapy is indicated for men with unequivocally low testosterone confirmed on morning labs plus consistent symptoms — not for men with normal labs who simply want to feel younger. The North American Menopause Society applies the same logic to estrogen and progesterone therapy in women: individualized to symptoms, timing since menopause onset, and personal risk factors, not prescribed off a checklist. Both societies exist because hormone therapy done loosely — over-treating men with borderline labs, or under-screening women for clot and cardiovascular risk before starting estrogen — causes real harm. That’s the standard I hold myself to, not a marketing line.

In men, the pattern is usually a cluster, not one complaint: low libido, harder time keeping muscle despite training, flatter mood, worse recovery, brain fog. One symptom means little. Three or four together, alongside a confirmed low total and free testosterone on two separate morning draws, is a different picture.

In women, perimenopause announces itself more directly — hot flashes, night sweats, disrupted sleep, vaginal dryness, mood swings, and weight redistribution. The harder cases are the quieter ones: fatigue, cognitive fog, and joint aches that show up years before periods actually stop, and that get waved off as “just stress” or “just getting older.”

Here’s the honest caveat: fatigue and mood changes have a dozen other causes — thyroid disease, sleep apnea, iron deficiency, depression, medication side effects. A program that skips straight from symptom quiz to prescription isn’t saving you time. It’s skipping the step that tells you whether hormones are even the right problem to treat.

The sequence at Summit is fixed, and it doesn’t move for anyone: history and symptoms first, bloodwork second, a plan built from what the labs actually show third. For men, that’s total and free testosterone, SHBG, and LH, plus a metabolic and lipid panel — because untreated metabolic dysfunction and declining testosterone compound each other, the same way the SELECT trial established that cardiometabolic risk is the villain driving outcomes, not a single number in isolation. For women, it’s a symptom-and-cycle history plus estrogen, FSH, and a thyroid panel, since thyroid dysfunction mimics menopause constantly and gets missed by any program that only checks the hormone it’s selling.

I review every chart myself before a prescription goes out. Not a nurse queue, not an algorithm that auto-approves a questionnaire. If your labs don’t support a deficiency, I’ll tell you that directly instead of writing the script anyway. That’s the same standard I apply to GLP-1 dosing, where decisions are grounded in trial-level evidence — STEP 1 and SURMOUNT-1 for semaglutide and tirzepatide dosing and escalation — rather than a flat protocol everyone gets regardless of how they’re tolerating it. Hormone therapy gets the same discipline: confirmed deficiency plus symptoms, not age or a subscription tier, decides who starts treatment.

Bioidentical means the hormone is molecularly identical to what your body produces — the same estradiol, the same progesterone, manufactured rather than made by your ovaries. It is not automatically safer or more “natural” than an FDA-approved synthetic or conjugated option. Several bioidentical formulations are themselves FDA-approved; several compounded versions are not FDA-regulated at all, which means dosing consistency depends entirely on which pharmacy compounds it.

A flat protocol picks one delivery method and one starting dose for every woman who walks in. I don’t. Delivery — oral, topical, or pellet — and starting dose depend on your labs, your symptom severity, and your personal risk factors (clotting history, cardiovascular risk, time since your last period). The honest answer to “is bioidentical better” is: better for what, tested how, monitored by whom. Those three questions matter more than the word on the label, and a subscription platform answering them with a form isn’t answering them at all.

Testosterone therapy is not a single injection and a refill schedule. Starting dose depends on your baseline labs and body composition, and it should change based on how you respond — not stay fixed because that’s what the protocol says. I recheck labs 6–8 weeks after starting or adjusting, then periodically after that, because the right dose in month one is frequently the wrong dose by month six.

Realistic timeline: libido and energy improvements often show up within the first few weeks; body composition and muscle changes take months and depend on training and diet doing their part too. I tell men this on day one so no one judges the medication by week two and quits before it’s had a chance to work. Low-T Center and similar flat-tier clinics tend to set one dose per tier and monitor loosely, if at all — which is a business model built around a subscription, not a treatment plan built around your labs.

You can get testosterone or estrogen prescribed online right now from Ro, Hims/Hers, or a dozen other platforms, in about the time it takes to fill out a form. What you won’t reliably get is the same clinician reviewing your labs at month one and month six, adjusting your dose based on how you actually responded, and knowing your history well enough to catch something a form can’t ask about. That’s the same anonymous-provider problem these platforms have with GLP-1 prescribing — a checkbox you click yourself is not the same as a physician reviewing your actual history.

Chattanooga’s own local health directories haven’t caught up to this yet — search “hormone replacement therapy chattanooga” and you’ll find flat-tier clinics and national telehealth brands, but no local option combining a named, board-certified physician with lab-driven dosing on every chart. I am that option. If your dose needs adjusting, you’re not submitting a ticket into a rotating queue — you’re getting a decision from the person who ordered your labs in the first place.

If you’ve been wondering whether what you’re feeling is age or something your labs would actually explain, that’s answerable. Ready to start? Apply at summitmetabolichealth.com/apply.

This content is for informational purposes and does not replace individualized medical advice. Hormone replacement therapy carries risks — including cardiovascular and clotting considerations — that should be discussed with a physician based on your personal and family health history.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *